<DOC>
	<DOCNO>NCT00773240</DOCNO>
	<brief_summary>The study assess pharmacodynamic effect tolerability Grazax treatment initiate grass pollen season subject seasonal grass pollen induce rhinoconjunctivitis</brief_summary>
	<brief_title>A Phase III Trial Assessing Pharmacodynamic Effect Tolerability Grazax Treatment</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<criteria>Positive skin prick test Phleum pratense Positive IgE Phleum pratense sign informed consent A clinical history moderate severe persistent rhinoconjunctivitis symptoms No uncontrolled asthma past 12 month No history IgE mediate systemic reaction due food , insect venom , kind medication induce exercise , symptom skin respiratory system without hypotension No history IgE mediate systemic reaction due food , insect venom , kind medication induce exercise , symptom skin respiratory system without hypotension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>